RVMD - Latest News
Revolution Medicines, Inc. (RVMD), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $43.64B. Beta to the broader market is 1.41.
The article list below shows the most recent RVMD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent RVMD Headlines
Revolution Medicines (NASDAQ:RVMD) Stock: Insider Elizabeth Anderson Sells 10,143 Shares
defenseworld.net - Sep 26, 2026
Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) Director Elizabeth Anderson sold 10,143 shares of the firm's stock in a transaction that
Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines?
fool.com - Sep 24, 2026
Revolution Medicines has just received good news around a drug meant to treat pancreatic cancer. While the company has multiple drugs in development,
Alan Sandler Sells 341 Shares of Revolution Medicines (NASDAQ:RVMD) Stock
defenseworld.net - Sep 20, 2026
Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) insider Alan Sandler sold 341 shares of Revolution Medicines stock in a transaction dated
Jack Anders Sells 4,053 Shares of Revolution Medicines (NASDAQ:RVMD) Stock
defenseworld.net - Sep 20, 2026
Revolution Medicines, Inc. (NASDAQ: RVMD - Get Free Report) CFO Jack Anders sold 4,053 shares of the company's stock in a transaction that occurred o
Axsome Therapeutics vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
fool.com - Sep 18, 2026
Axsome Therapeutics is generating rapid revenue growth through its expanding portfolio of commercialized central nervous system treatments. Revolutio
How News Affects RVMD Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track RVMD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked RVMD news questions
- What is the latest RVMD news headline?
- The most recent RVMD headline (Sep 26, 2026) is "Revolution Medicines (NASDAQ:RVMD) Stock: Insider Elizabeth Anderson Sells 10,143 Shares". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the RVMD news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What RVMD news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual RVMD options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.